CSIMarket
 

Dyax Corp  (DYAX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Dyax's Working Capital Per Sales

DYAX's Working Capital and Revenue growth



DYAX Working Capital Per Revenue (Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
Y / Y Working Capital Change 64.44 % 114.61 % -0.56 % 77.94 % 351.56 %
Y / Y Revenue Change 12.44 % 34.66 % 44.63 % 64.76 % 60.64 %
Working Capital Per Revenue 2.72 2.49 2.09 2.25 2.29
Total Ranking # 3802 # 3771 # 3775 # 3785 # 3801
Seq. Working Capital Change -22.26 % 115.74 % -2.78 % 0.86 % 1.46 %
Seq. Revenue Change -6.23 % 29.17 % -21.55 % 18.35 % 12.3 %





Comment on DYAX's Working Capital Per Revenue in the third quarter 2015
Dyax's Working Capital Per Revenue sequentially grew to 2.72 during the Q3 2015, a new company high.

Within Healthcare sector 48 other companies have achieved lower Working Capital Per Revenue during the Q3 2015. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2015, compared to previous quarter from 3771 to 3802.
Working Capital Per Revenue Ranking
Within: No.
Industry # 6
Sector # 49
S&P 500 # 3802


Working Capital Per Revenue Statistics
High Average Low
2.72
1.9
0.64
(Sep 30 2015)   (Sep 30 2013)



Financial Statements
Dyax's Working Capital $ 304 Millions Visit DYAX's Balance sheet
Dyax's Revenues $ 25 Millions Visit DYAX's Income Statement
Where are DYAX's Sales coming from? Visit DYAX's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2015, within Healthcare Sector Working Capital Per Revenue
Novavax inc  7.18 
Icagen, Inc.  7.18 
Xencor Inc  6.95 
Acceleron Pharma inc  6.82 
Melinta Therapeutics, Inc.  6.75 
Oncomed Pharmaceuticals Inc  6.29 
Innoviva Inc   6.24 
Applied Genetic Technologies Corporation  6.07 
Viracta Therapeutics Inc   6.03 
Theravance Biopharma inc   5.84 
Clearday Inc   5.37 
Agenus Inc  5.31 
Oragenics Inc   5.08 
Agios Pharmaceuticals Inc   4.79 
Acer Therapeutics Inc   4.37 
Aethlon Medical Inc   4.34 
Geovax Labs Inc   4.20 
Sangamo Therapeutics Inc   4.18 
Arena Pharmaceuticals Inc   4.00 
Cerevel Therapeutics Holdings Inc   3.93 
Talphera Inc   3.77 
Therapeuticsmd Inc   3.58 
Omeros Corp  3.48 
Adamas Pharmaceuticals Inc  3.39 
Lineage Cell Therapeutics Inc   3.27 
Inovio Pharmaceuticals Inc   3.22 
Arqule Inc  3.16 
Momenta Pharmaceuticals inc   3.16 
Teligent Inc   3.06 
Nutrastar International Inc.  3.00 
Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com